Dyslipidemia Management
There is no content available at this time. Please check again later.
Relevant Content
Subclinical Diabetic Cardiomyopathy: Detectable but Not Yet Actionable
Distribution and Clinical Utility of the Kidney Disease Improving Global Outcomes Chronic Kidney Disease Risk Classification in Patients Undergoing Atrial Fibrillation Ablation
Journal of the American Heart Association, Ahead of Print.
PFKFB2 Gates a Relationship Between Cardiac Glycolytic Regulation and Electrophysiological Function
Circulation: Arrhythmia and Electrophysiology, Ahead of Print.
BACKGR...
State of Cardiovascular Disease and Stroke in Hispanic Latino Adults in the United States
BACKGR...
This scientific statement reviews CVD epidemiology in Hispanic populations...
Science News from #EPI|Lifestyle25
Exclusive interviews from keynote speakers, presenters and award-winning c...
Lipoprotein(a): An Atherosclerotic Cardiovascular Disease Risk Factor That Can No Longer Be Ignored
Journal of the American Heart Association, Ahead of Print.
Background...
Associations of Cardiovascular–Kidney–Metabolic Syndrome With All‐Cause and Cardiovascular Death and the Progression of Cardiovascular–Kidney–Metabolic Syndrome Among Hong Kong Chinese People Over 2 Decades
Background...
Journal of the American Heart Association, Ahead of Print.
Background...
Elevated Endogenous Insulin and Insulin Resistance Are Associated With Progressive Diastolic Dysfunction and Worse Cardiovascular Outcomes
Background...
Circulation: Heart Failure, Ahead of Print.
BACKGROUND:Although diabe...
Methodologic Standards for Follow-Up Extension in Cardiovascular Trials
BACKGROUND:Although diabe...
Extension follow-up studies address long-term questions beyond the parent...
Rheumatologic Disease as a Substrate for HFpEF: Pathophysiological Mechanisms and Clinical Implications
Journal of the American Heart Association, Volume 15, Issue 15, August 4,...